USPTO trademark

ARYNTA

RegisteredUSPTOWord markClass 5

"ARYNTA" is a word mark owned by Azurity Pharmaceuticals, Inc., filed at the USPTO on April 8, 2025. It is registered and covers class 5 (Pharmaceuticals).

View Azurity Pharmaceuticals, Inc. portfolio Get this data via the API

Data current as of October 13, 2026Official USPTO record

As filed with the USPTO

Status: Registered; Since October 13, 2026
Filed: April 8, 2025
Registered: October 13, 2026
Expires: Not recorded
Application no.: 99126104
Registration no.: 8504566
Office: USPTO; United States Patent and Trademark Office
Mark type: Word mark; 1 class

Ownership

Who owns ARYNTA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Azurity Pharmaceuticals, Inc.

Woburn, United States

125 trademarks in the portfolioView company

Representative

Douglas R. Wolf

Wolf Greenfield & Sacks, P.C.

Goods and services

What the mark covers

The products and services ARYNTA is filed for, grouped by Nice class.

05Class 5 · Pharmaceuticals
Pharmaceutical preparations acting on the central nervous system

History

What has happened so far

Steps recorded by the USPTO, newest first.

October 13, 2026Notice of registration confirmation emailed
October 13, 2026Registered-principal register
September 21, 2026Notice of acceptance of statement of use e-mailed
September 21, 2026Allowed principal register - sou accepted
August 19, 2026Notice of approval of extension request e-mailed
August 18, 2026Statement of use processing complete
August 18, 2026Sou extension 1 granted
August 13, 2026Case assigned to intent to use paralegal
May 20, 2026Use amendment filed
May 20, 2026Sou teas extension received

10 earlier steps on the official record.

FAQ

About ARYNTA

Who owns the trademark "ARYNTA"?

The USPTO trademark "ARYNTA" (application 99126104) is owned by Azurity Pharmaceuticals, Inc.

What is the status of "ARYNTA"?

Its status at the USPTO is: registered.

When was "ARYNTA" registered?

It was registered on October 13, 2026.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ARYNTA and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2aa7-185d-76bb-bb53-b3cf1d3fe843
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2aa7-185d-76bb-bb53-b3cf1d3fe843",
  "object": "trademark",
  "mark_text": "ARYNTA",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "99126104",
  "filing_date": "2025-04-08",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Azurity Pharmaceuticals, Inc.",
      "entity_id": "ent_019eb725-e6a7-73db-81c8-7bbc8473b1bf"
    }
  ]
}